NDRA (ENDRA Life Sciences) Moat Score: 4/10 (As of Jul. 03, 2026)


NDRA ENDRA Life Sciences Inc NDRA
25 GF Score
Price $4.72
! 2 Warning Signs
View Full Analysis

What is ENDRA Life Sciences Moat Score?

ENDRA Life Sciences NDRA -4.84% 25 Moat Score is 4 as of Jul. 03, 2026. GuruFocus rates NDRA with a GF Score™ of 25/100. The stock has 2 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, ENDRA Life Sciences ranks better than 82.87% on this metric.

ENDRA Life Sciences has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

ENDRA Life Sciences has Narrow Moat: ENDRA Life Sciences has a discernible moat due to its proprietary technology in medical imaging. However, the company's market position is still developing, and it faces competition from larger, established players, limiting its moat to a modest level.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes ENDRA Life Sciences might have Narrow Moat - Discernible but modest moat.

ENDRA Life Sciences  (NAS:NDRA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

ENDRA Life Sciences Moat Score Related Terms

NDRA vs BIAF, ADVB, MBAI: Moat Score Comparison

For the Diagnostics & Research subindustry, ENDRA Life Sciences's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ENDRA Life Sciences Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ENDRA Life Sciences's Moat Score distribution charts can be found below:

* The bar in red indicates where ENDRA Life Sciences's Moat Score falls into.


NDRA
25GF Score
ENDRA Life Sciences Inc NDRA
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
ENDRA Life Sciences (NDRA) has a Moat Score of 4 as of Jul. 03, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, ENDRA Life Sciences ranks #37 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 17.1%.
Is ENDRA Life Sciences' Moat Score too high?
ENDRA Life Sciences' current Moat Score is 4. Based on the distribution chart, ENDRA Life Sciences ranks #37 out of 216 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, ENDRA Life Sciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENDRA Life Sciences' Moat Score compare to BIAF and ADVB?
According to the Medical Diagnostics & Research industry distribution chart, ENDRA Life Sciences ranks #37 out of 216 companies for Moat Score. This places ENDRA Life Sciences in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. ENDRA Life Sciences's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENDRA Life Sciences stock overvalued right now?
ENDRA Life Sciences (NDRA) has a current Moat Score of 4. The current Moat Score is 4. ENDRA Life Sciences' overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For ENDRA Life Sciences (NDRA), the current Moat Score is 4 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENDRA Life Sciences Business Description

Address 3600 Green Court, Suite 350, Ann Arbor, MI, USA, 48105-1570
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
25GF Score

Get the complete analysis for NDRA

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.72
Price